Single User License: $2750
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
The global single nucleotide polymorphism (SNP) genotyping market was valued at $3.5 billion in 2013. This market is expected to reach $4.3 billion in 2014 and $11.5 billion in 2019, a compound annual growth rate (CAGR) of 21.9% from 2014 to 2019.
Report Includes
- An overview of the global markets for single nucleotide polymorphism genotyping.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- A geographic breakdown into the regions of North America, Europe, Asia-Pacific (APAC), and the rest of the world.
- Information on the market's dynamics as well as innovations and current trends.
- Analysis of the regulatory environment and its impact.
- Evaluation of market drivers, restraints, and opportunities.
- Relevant patent analysis.
Report Scope
This research report incorporates an in-depth analysis of the SNP genotyping market, including market estimations and trends through 2019. Major players, competitive intelligence, technologies, applications, market dynamics and geographic opportunities are discussed in detail in the report. The report discusses recent developments and the product portfolios of the major players. Patent analysis in the report focuses on providing technological trends across the last few years in regions such as the U.S., Europe and Japan. The report presents market analysis and estimates CAGR (compound annual growth rate) for SNP genotyping technologies and geographies.
Analyst Credentials
Vijay Laxmi has more than 20 years of domain experience. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and has handled projects for various consultancies. She has authored market research studies in the healthcare domain. Some of these include the following:
- Various medical devices markets.
- High-growth and niche markets in healthcare and life sciences.
- Home healthcare market.
- Medical tourism.
Recent Reports
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
RNAi Technologies and Global Markets
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
Metabolomics: Technologies and Global Markets
The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.
Global Recombinant Proteins Market
The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More